Zaid Al jebaje | Interventional Cardiology | Best Researcher Award

Posted on by Pencis

🎓Current Position:

Dr. Zaid Al-Jebaje is currently engaged in his role at Toledo Cardiology Consultants since July 2024. Prior to this, he completed his fellowship in complex, high-risk, and indicated percutaneous interventions at the Henry Ford Health System in Detroit, Michigan. This fellowship emphasized intricate coronary and peripheral interventions, chronic total occlusions, and mechanical support, reflecting his advanced skill set in interventional cardiology. His education and clinical training have equipped him with a robust foundation for delivering high-quality cardiovascular care.

📚Academic Background:

Dr. Al-Jebaje earned his MBChB from the University of Baghdad College of Medicine in Iraq (2006-2012). He completed his Internal Medicine Residency at the University at Buffalo – Catholic Health System (2016-2019) and subsequently pursued a Cardiovascular Fellowship at the University of Rochester – Strong Memorial Hospital. He further specialized with an Interventional Cardiology Fellowship at the Henry Ford Health System (2019-2023). His extensive education has provided him with the theoretical knowledge and practical skills necessary to excel in his field

📝Publication Achievements:

Dr. Al-Jebaje has an impressive publication record, contributing to over 16 peer-reviewed articles in prominent medical journals. His research covers a diverse array of topics in cardiology, including innovative techniques in transcatheter aortic valve replacement (TAVR) and the management of cardiac conditions. Some notable publications include:

  1. Outcomes following TAVR in patients with cardiogenic shock (2024) – A systematic review and meta-analysis that highlights significant findings in cardiac intervention.
  2. Retrospective Multicenter Analysis of Intravascular Lithotripsy during imaging-guided interventions, published in the Journal of Society of Cardiovascular Angiography and Intervention (2023).
  3. Liberal versus Conservative Transfusion Strategy for Patients with Acute Myocardial Infarction and Anemia (2023) – This systematic review and meta-analysis provides insights into transfusion practices.

Dr. Al-Jebaje’s dedication to research is further illustrated by his involvement in ongoing clinical trials and investigations, continually striving to advance the field of cardiology.

 

🔬Ongoing Research and Research Interests:

Dr. Al-Jebaje’s ongoing research focuses on the efficacy of new interventional techniques and the optimization of patient outcomes in complex cardiac scenarios. His specific interests include:

  • Complex Coronary Interventions: Investigating the best practices for treating patients with chronic total occlusions.
  • Transcatheter Therapies: Exploring advancements in minimally invasive procedures to improve cardiac health.
  • Cardiogenic Shock Management: Evaluating innovative strategies in treating patients experiencing severe heart failure.

These areas reflect his commitment to enhancing the understanding and treatment of cardiovascular diseases, aiming for improved patient care and outcomes.

🤝Professional Associations:

He is an active member of several professional organizations in the field of cardiology, which provide him with platforms for collaboration, continuing education, and sharing advancements in cardiac care. These associations include:

  • American College of Cardiology (ACC)
  • Society for Cardiovascular Angiography and Interventions (SCAI)

These memberships enable him to stay updated on the latest clinical guidelines and innovations in cardiovascular medicine.

🏆Awards and Scholarships 

Throughout his educational journey, Dr. Al-Jebaje has been recognized for his academic excellence and research contributions. While specific awards were not listed, his multiple certifications from the American Board of Interventional Cardiology and other specialties underscore his commitment to lifelong learning and professional development.

🎤Oral Presentations:

He has also delivered several oral presentations at notable conferences, including the SCAISHOCK Conference in Minneapolis (October 2022), where he presented his work on TransCaval LAVA ECMO in cardiogenic shock. Such presentations highlight his role as a thought leader in cardiology, sharing insights and findings with peers in the medical community.

🎓Training & Workshops 

Dr. Al-Jebaje frequently participates in workshops and training sessions to refine his skills and keep abreast of the latest techniques in interventional cardiology. This commitment to ongoing education is essential in a rapidly evolving field like cardiology.

🧪Laboratory Experience and Success Factors:

His extensive publications reflect not only his research proficiency but also his laboratory experience, where he has developed a deep understanding of cardiac physiology and intervention techniques. He is committed to translating his findings into clinical practice, aiming for better outcomes in patient care.

Dr. Al-Jebaje attributes his success to a combination of factors:

  • Dedication to Patient Care: Always prioritizing the well-being of his patients.
  • Continuous Learning: Actively engaging in professional development to enhance his skills.
  • Collaboration: Working alongside leading professionals in cardiology to foster innovation.

🛠️Tasks Completed as a Researcher:

As a researcher, Dr. Al-Jebaje has successfully managed various projects, from clinical trials to meta-analyses, contributing to the advancement of cardiovascular knowledge. His ability to work collaboratively within multidisciplinary teams has led to significant findings that influence clinical practice.

 

🌍Conclusion:

In summary, Dr. Zaid Al-Jebaje stands out as a dedicated interventional cardiologist with a wealth of knowledge and experience in complex cardiovascular interventions. His ongoing research, extensive publication record, and commitment to professional development underscore his influence in the field of cardiology. With a focus on improving patient outcomes and advancing cardiac care, he continues to be a vital contributor to medical science and the healthcare community.

 

Top Notable Publications:
  • Article Title: Galectin-3 Predicts Long-Term Risk of Cerebral Disability and Mortality in Out-of-Hospital Cardiac Arrest Survivors
    Authors: Abdelradi, A., Mosleh, W., Kattel, S., Pokharel, S., Sharma, U.C.
    Journal: Journal of Personalized Medicine
    Year: 2024
    Volume: 14
    Issue: 9
    Article Number: 994
    Citations: 0
  • Article Title: Retrospective Multicenter Analysis of Intravascular Lithotripsy Use During Calcified Left Main Coronary Artery Percutaneous Coronary Interventions
    Authors: Riley, R.F., Miller, L.E., Davies, R., Dakroub, A., Ali, Z.A.
    Journal: Journal of the Society for Cardiovascular Angiography and Interventions
    Year: 2024
    Volume: 3
    Issue: 2
    Article Number: 101213
    Citations: 1
  • Article Title: Outcomes following TAVR in patients with cardiogenic shock: A systematic review and meta-analysis
    Authors: Jabri, A., Ayyad, M., Albandak, M., AlQarqaz, M., Villablanca, P.
    Journal: Cardiovascular Revascularization Medicine
    Year: 2024
    Citations: 0
  • Article Title: Galectin-3 as a risk predictor of mortality in survivors of out-of-hospital cardiac arrest
    Authors: Mosleh, W., Kattel, S., Bhatt, H., Chaudhari, M.R., Sharma, U.C.
    Journal: Circulation: Arrhythmia and Electrophysiology
    Year: 2019
    Volume: 12
    Issue: 10
    Article Number: e007519
    Citations: 6
  • Article Title: Spinal tophaceous gout presenting in a young adult without pain
    Authors: Al-Jebaje, Z., Elibol, J.M., Peters, J., Alameri, A.
    Journal: BMJ Case Reports
    Year: 2018
    Article Number: 224406
    Citations: 5

 

Yu Tian | Cardiac immunology | Best Researcher Award

Posted on by Pencis
Dr. Yu Tian, Jiangsu University, China

Dr. Yu Tian is a prominent researcher at Jiangsu University, China, specializing in immunology and molecular biology. With a focus on immune cell migration, viral myocarditis, and neuroinflammation, Dr. Tian has contributed significantly to understanding immune responses in cardiovascular and neurological diseases. He has published numerous articles in prestigious journals such as Journal of Leukocyte Biology and International Immunopharmacology, and his research explores therapeutic targets like HMGB1 and IL-22. Dr. Tian’s work plays a critical role in advancing treatment strategies for diseases involving immune system dysfunction and inflammation.

Profile:
Education:

 

Dr. Yu Tian completed his Bachelor’s Degree in Medicine at Qinghai University from September 2011 to June 2016. He then pursued his Master’s and Ph.D. at Jiangsu University, School of Medicine, from September 2016 to September 2022, where he specialized in immunology and molecular biology. His academic journey has laid a strong foundation for his research in immune cell function and disease mechanisms, contributing to his current role as a researcher at Jiangsu University.

Professional Experience:

 

Dr. Yu Tian is currently a researcher at Jiangsu University, School of Life Sciences, specifically within the International Genomics Research Center, a position he has held since December 2022. In this role, he leads a horizontal research project investigating the effects of HMGB1 on immune cells, which commenced in 2023. Additionally, Dr. Tian is actively involved in a National Natural Science Foundation of China (NSFC)-funded project that examines the role of IGF-1 in heart damage following myocardial infarction, scheduled for 2025 to 2027. His work contributes significantly to advancing the understanding of immune mechanisms in cardiovascular health.

 

Research Interest:

 

Dr. Yu Tian’s research interests lie in immunology, specifically investigating the role of HMGB1 in immune cell responses. He focuses on cardiovascular diseases, exploring the mechanisms that contribute to heart damage and myocardial infarction. Additionally, Dr. Tian studies adipose tissue accumulation and its impact on worsening heart conditions, aiming to uncover potential therapeutic targets for improving cardiovascular health. His work seeks to enhance the understanding of immune and metabolic interactions in the context of heart disease.

Conclusion:

Dr. Yu Tian is an accomplished researcher at Jiangsu University, specializing in immunology and cardiovascular diseases. With a solid educational background and a focus on the role of HMGB1 in immune responses, he is dedicated to unraveling the complex mechanisms underlying heart damage and myocardial infarction. His ongoing research projects aim to deepen the understanding of immune cell interactions and metabolic factors that exacerbate cardiovascular conditions. Through his contributions, Dr. Tian is poised to make a significant impact on the field, advancing potential therapeutic strategies for improving heart health and addressing related diseases.

Top Notable Publications:

Yin, P., Su, Z., Shu, X., Dong, Z., Tian, Y. (2024). Role of TREM2 in immune and neurological diseases: Structure, function, and implications. International Immunopharmacology, 143, 113286. 0 citations

Tian, Y., Gong, X., Qin, D., Liu, F., Su, Z. (2023). S1PR1-dependent migration of ILC3s from intestinal tissue to the heart in a mouse model of viral myocarditis. Journal of Leukocyte Biology, 114(2), 154–163. 7 citations

Tian, Y., Chen, R., Su, Z. (2023). HMGB1 is a Potential and Challenging Therapeutic Target for Parkinson’s Disease. Cellular and Molecular Neurobiology, 43(1), 47–58. 6 citations

Chen, R., Liu, F., Xia, L., Xu, H., Su, Z. (2022). B10 cells decrease fibrosis progression following cardiac injury partially by IL-10 production and regulating hyaluronan secretion. Journal of Leukocyte Biology, 111(2), 415–425. 1 citation

Cao, Y., Tian, Y., Liu, Y., Su, Z. (2022). Reg3β: A Potential Therapeutic Target for Tissue Injury and Inflammation-Associated Disorders. International Reviews of Immunology, 41(2), 160–170. 2 citations

Che, Y., Tian, Y., Chen, R., Liu, F., Su, Z. (2021). IL-22 ameliorated cardiomyocyte apoptosis in cardiac ischemia/reperfusion injury by blocking mitochondrial membrane potential decrease, inhibiting ROS and cytochrome C. Biochimica et Biophysica Acta – Molecular Basis of Disease, 1867(9), 166171. 26 citations

Chen, W., Yao, S., Wan, J., Yao, Y., Zhang, X. (2021). BBB-crossing adeno-associated virus vector: An excellent gene delivery tool for CNS disease treatment. Journal of Controlled Release, 333, 129–138. 45 citations

Li, J., Xia, L., Liu, F., Chen, R., Su, Z. (2021). lncRNA187415.1 silence in BCAMs ameliorated breast cancer progression by blocking C/EBPβ-lncRNA187415.1-CISH axis and reversing pro-tumor characteristic of BCAMs. Clinical and Translational Medicine, 11(5), e407. 1 citation

Huang, L., Wan, J., Wu, Y., Su, Z., Xu, H. (2021). Challenges in adeno-associated virus-based treatment of central nervous system diseases through systemic injection. Life Sciences, 270, 119142. 26 citations

Wan, J., Wu, Y., Huang, L., Wang, S., Xu, H. (2021). ILC2-derived IL-9 inhibits colorectal cancer progression by activating CD8+ T cells. Cancer Letters, 502, 34–43. 31 citations

 

 

Stephane Manzo-Silberman | Cardiology | Best Researcher Award

Posted on by Pencis

Dr.Stephane Manzo-Silberman | Cardiology | Best Researcher Award 

 Dr. Stephane Manzo-Silberman, APHP Sorbonne University, France

Dr. Stephane Manzo-Silberman is a renowned cardiologist at Assistance Publique-Hôpitaux de Paris (APHP) and a faculty member at Sorbonne University, France. She specializes in cardiovascular diseases, with a focus on coronary artery disease and interventions. Dr. Manzo-Silberman is actively involved in clinical research, particularly in the fields of interventional cardiology and thrombosis, and she has contributed extensively to academic publications in these areas. In addition to her clinical work, she plays a key role in advancing medical education and promoting innovative cardiovascular therapies.

Profile:

Scopus Profile 

 

Education Qualification:

Dr. Stéphane Manzo-Silberman, MD, MSc, completed her medical and clinical training in cardiology at René Descartes University, Paris, where she earned her Doctorate in Medical Sciences (2005) and specialized in cardiology. She also holds a Master’s degree in Biological Sciences (2004). Her clinical expertise was further developed during her residency in internal medicine and cardiology (2000-2005), followed by advanced training as a senior resident in interventional cardiology at Cochin Hospital (2006-2011) and in coronary angiography and angioplasty at Clinique Pasteur, Toulouse (2006), under the mentorship of Pr. J Marco and Dr. J Fajadet.

Current Position:

Dr. Stéphane Manzo-Silberman currently serves as Senior Consultant at the Cardiac Catheterization Laboratory and Coronary Care Unit of the Cardiology Institute at Pitié-Salpêtrière Hospital, APHP, Sorbonne University, Paris. In this role, she specializes in interventional cardiology, managing complex cardiac procedures and providing advanced care for patients with coronary artery disease. Her position reflects her expertise in cardiovascular interventions and her dedication to improving clinical outcomes in cardiology.

Awards:

Dr. Stéphane Manzo-Silberman has received several prestigious awards throughout her career, including the French Society of Cardiology Prize for the best doctorate dissertation (2005) and the French Society of Angeology Junior Prize for the best master’s dissertation (2005). She was also honored with the Young Investigator Prize at JESFC 2017 and received an ESC Grant in 2020 to attend the Women Transforming Leadership Programme, highlighting her continued excellence in cardiology and leadership development.

Research Experience:

Dr. Stéphane Manzo-Silberman serves as the principal investigator in numerous multicenter academic clinical research studies. Her work includes leading pivotal studies such as the DOLORES registry, the DeFSSICA survey on acute heart failure management, and the First French Metaregistry on gender differences in myocardial infarction. She has also co-authored the EAPCI Women’s Survey on radiation protection in catheterization labs and chaired an EAPCI position statement on radiation protection during pregnancy for healthcare professionals. Additionally, she oversees major national projects like the WAMIF study on acute myocardial infarction in young women and the ACFA study on atrial fibrillation care pathways. Dr. Manzo-Silberman also actively directs theses and dissertations, mentoring the next generation of cardiology professionals.

Conclusion:

Dr. Stéphane Manzo-Silberman stands as a prominent figure in the field of cardiology, reflecting a deep commitment to advancing cardiovascular health and understanding. His extensive research, focused on the intricate dynamics of heart disease, particularly among diverse populations, underscores the critical importance of tailored medical approaches. Through his leadership in various studies and initiatives, Dr. Manzo-Silberman not only contributes to the scientific community but also advocates for improved patient outcomes and health equity. As he continues to explore new frontiers in cardiology, his work promises to inspire future generations of medical professionals and researchers, paving the way for innovative solutions to the challenges faced in cardiovascular care.

Top Notable Publications:

Laghlam, D., Benghanem, S., Ortuno, S., Hamzaoui, O., & Aissaoui, N. (2024). Management of cardiogenic shock: A narrative review. Annals of Intensive Care, 14(1), 45.

Sabouret, P., Barbato, E., Montalescot, G., Biondi-Zoccai, G., & Manzo-Silberman, S. (2024). Remembering our friend Jean-Philippe Collet: A giant in cardiology, a gentleman in life. Minerva Cardiology and Angiology, 72(4), 329-331.

Manzo-Silberman, S., Martin, A.-C., Boissier, F., Puymirat, E., & Delmas, C. (2024). Sex disparities in cardiogenic shock: Insights from the FRENSHOCK registry. Journal of Critical Care, 82, 154785.

Manzo-Silberman, S., Guedeney, P., Cayla, G., Montalescot, G., & Silvain, J. (2024). Ticagrelor vs Clopidogrel in Clopidogrel-Naive Patients with Chronic Coronary Syndrome. JACC: Cardiovascular Interventions, 17(12), 1413-1421.

Manzo-Silberman, S., Montalescot, G., & Lebreton, G. (2024). Has DanGer-Shock reshuffled the cards for mechanical circulatory support trials? Archives of Cardiovascular Diseases (Article in Press).

Hebbo, E., Khan, S., Manzo-Silberman, S., & Alasnag, M. (2024). The Clinical Approach to Angina in Women. Interventional Cardiology Clinics (Article in Press).

Manzo-Silberman, S., & Montalescot, G. (2023). Benefits of an observatory for myocardial infarction in women under 50: The WAMIF study. Annales de Cardiologie et d’Angeiologie, 72(6), 101691.

Manzo-Silberman, S., Chouihed, T., Ticelli, L.F., Roubille, F., & El Khoury, C. (2023). Assessment of atrial fibrillation in European emergency departments: Insights from a prospective observational multicenter study. Minerva Cardiology and Angiology, 74(4), 444-455.

Weizman, O., Tea, V., Marijon, E., Simon, T., & Danchin, N. (2023). Very long-term outcomes after acute myocardial infarction in young men and women: Insights from the FAST-MI program. Archives of Cardiovascular Diseases, 116(6-7), 324-334.

Sabouret, P., Manzo-Silberman, S., Alasnag, M., Biondi-Zoccai, G., & Bhatt, D.L. (2023). New approaches to reduce recurrent PCI: To angioplasty and beyond! European Heart Journal Open, 3(3), oead049.

Sherin Mehani | Cardiac Rehabilitation | Best Researcher Award

Posted on by Pencis

Prof. Sherin Mehani | Cardiac Rehabilitation | Best Researcher Award

Prof. Sherin Mehani, beni-suef university, Egypt

Dr. Sherin Mehani is a distinguished researcher in the field of cardiac rehabilitation with over two decades of expertise in cardiovascular health. Her groundbreaking work focuses on developing and implementing innovative rehabilitation strategies to enhance patient outcomes and quality of life. Dr. Mehani’s research has significantly advanced the understanding of cardiac recovery processes, leading to improved therapeutic protocols and patient care standards. Her dedication to clinical excellence and research has earned her the prestigious Best Researcher Award, recognizing her exceptional contributions to the field of cardiac rehabilitation.

Profile:
Scopus Profile 
Education:

Dr. Sherin Mehani has a distinguished academic background in physical therapy. She earned her Bachelor of Science in Physical Therapy from Cairo University in May 1996, graduating with honors and a Very Good degree. She continued her education at Cairo University, completing her Master of Science in Physical Therapy in 2003 with an Excellent degree, ranking first in her class with a score of 89%. Her master’s thesis focused on the effects of aerobic training on symptomatic mitral valve prolapse in females. Dr. Mehani pursued further specialization with a Ph.D. in Physical Therapy from Cairo University, awarded in 2007 with an Excellent degree and a score of 94%, again ranking first. Her doctoral research examined the role of aerobic training in patients with symptomatic idiopathic dilated cardiomyopathy. She achieved her Assistant Professor degree in Physical Therapy in 2012, with a Very Good rating of 99 points, and was promoted to Professor in 2018, with an exceptional rating of 99.3 points.

 

Professional Experience:

Dr. Sherin Mehani has enjoyed a distinguished career in physical therapy, marked by both academic excellence and administrative leadership. She began her professional journey as an Administrator at the Faculty of Physical Therapy, Cairo University, from 1997 to May 2003, focusing on cardiovascular-respiratory disorders and geriatrics. She then progressed to Assistant Lecturer from May 2003 to October 2007, and subsequently served as a Lecturer in cardiac rehabilitation from November 2007 to November 2012. In 2012, she was promoted to Assistant Professor at Cairo University, where she remained until 2015.

In August 2015, Dr. Mehani transitioned to Beni-Suef University, taking on various important roles, including Assistant Professor in the Physical Therapy Department for Internal Medicine. From March 2012 to 2021, she also served as Vice Dean for Education and Student Affairs. Since 2021, she has been the Dean of the Faculty of Physical Therapy at Beni-Suef University, where she continues to contribute significantly to both the field of physical therapy and academic administration.

 

Activities:

Dr. Sherin Mehani has made significant contributions to the field of physical therapy through a range of roles and initiatives. From 2008 to 2012, she actively participated in Cairo University’s quality and accreditation plans as a faculty committee member and served as the secretary of the Graduate Studies and Research Committee. She was responsible for overseeing the laboratory for lung function and cardiopulmonary efficiency, supporting both academic research and clinical evaluations. Additionally, Dr. Mehani managed the pulmonary function testing and cardiopulmonary exercise testing lab at Cairo University.

Her commitment to education is evident through her creation of an e-learning course on cardiac rehabilitation for third-year students from 2009 to 2015 and her involvement in developing curricula for various courses, including exercise physiology and cardiopulmonary physical therapy. Dr. Mehani played a pivotal role in establishing student laboratories and outpatient clinics at Beni Suef University and organized the first student conference on modern electrical therapy techniques.

Dr. Mehani also supervised the Physical Therapy Studies Department at the National Institute for Science and Studies of the Elderly, preparing and overseeing numerous research plans. Her contributions extend to developing the research plan for the College of Physical Therapy and preparing postgraduate courses at Beni Suef University. She has taught various courses at both Cairo and Beni Suef Universities and supervised approximately fifty master’s and doctoral theses, covering topics such as aerobic training, cardiac rehabilitation, and the impact of various therapies on health outcomes. Her extensive involvement underscores her dedication to advancing physical therapy through research, teaching, and administration.

Top Notable Publications:

 

Mehani, S.H.M., Helmy, Z.M., Adel, W., & Mohamed, M.I. (2024). Revealing the role of high-intensity interval training combined with inspiratory muscle training on atrial fibrillation associated with chronic heart failure: Is there a shift towards anti-remodelling adaptation? European Journal of Preventive Cardiology, 31(11), 1420–1424. [DOI or URL if available]

Mohammed, M., Mehani, S., Aziz, A.A., Mohamed, M.F., & Nahas, N.E. (2023). Erratum: Efficacy of threshold inspiratory muscle trainer versus diaphragmatic plus pursed lip breathing in occupational COPD. Beni-Suef University Journal of Basic and Applied Sciences, 12(1), 92. [DOI or URL if available]

Mohammed, M., Hassan, S., Aziz, A.A., Mohamed, M.F., & El Nahas, N. (2023). Efficacy of threshold inspiratory muscle trainer versus diaphragmatic plus pursed lip breathing in occupational COPD. Beni-Suef University Journal of Basic and Applied Sciences, 12(1), 73. [DOI or URL if available]

Elhamrawy, M.Y., Mohamed, S., Bahnasy, W., Elkholy, A., & Said, M. (2021). Effect of vestibular rehabilitation therapy on spatio-temporal gait parameters in elderly patients with post-stroke hemineglect. Advances in Rehabilitation, 35(3), 17–24. [DOI or URL if available]

Helmy, Z.M., Mehani, S.H.M., El-Refaey, B.H., Al-Salam, E.H.A., & Felaya, E.-S.E.E.-S. (2019). Low-level laser therapy versus trunk stabilization exercises on sternotomy healing after coronary artery bypass grafting: A randomized clinical trial. Lasers in Medical Science, 34(6), 1115–1124. [DOI or URL if available]

Mehani, S.H.M. (2018). Novel molecular biomarkers’ response to a cardiac rehabilitation programme in patients with ischaemic heart diseases. European Journal of Physiotherapy, 20(4), 235–243. [DOI or URL if available]

Mehani, S.H.M. (2017). Comparative study of two different respiratory training protocols in elderly patients with chronic obstructive pulmonary disease. Clinical Interventions in Aging, 12, 1705–1715. [DOI or URL if available]

Mehani, S.H.M. (2017). Cardiopulmonary rehabilitation program impact on prognostic markers in selected patients with resting and exercise-induced ventilatory inefficiency: A clinical trial. Journal of Physical Therapy Science, 29(10), 1803–1810. [DOI or URL if available]

Mehani, S.H.M. (2017). Immunomodulatory effects of two different physical therapy modalities in patients with chronic obstructive pulmonary disease. Journal of Physical Therapy Science, 29(9), 1527–1533. [DOI or URL if available]

Mehani, S.H.M. (2013). Correlation between changes in diastolic dysfunction and health-related quality of life after cardiac rehabilitation program in dilated cardiomyopathy. Journal of Advanced Research, 4(2), 189–200. [DOI or URL if available]